ArticleCurrent oncology (Toronto, Ont.)2025

SUVmax-IPI as a New Prognostic Index in Metastatic Non-Small Cell Lung Cancer Patients Receiving Nivolumab.

Nagihan Kolkıran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.